Publication | Closed Access

Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study

Bone DiseaseBone HealthGlucocorticoid-induced OsteoporosisDenosumab Versus RisedronateNon-inferiority StudyMedicineOsteoporosisBone MetabolismRheumatoid Arthritis